David Jackson

David Jackson is Professor of Respiratory Medicine at King’s College London and Head of the regional Severe Asthma and Eosinophilic Lung Disease Service based at Guy's Hospital in London. This unit is one of the largest of its kind in the world with over 1000 patients on biologic therapies and daily multidisciplinary clinics for severe asthma and EGPA. Professor Jackson has an MSc in Allergy and PhD in the pathophysiology of virus-induced asthma exacerbations from Imperial College London. He has published widely in the field of type 2 immunity, asthma and eosinophil associated diseases, and co-edited the European Respiratory Society Monograph on Eosinophilic Lung Diseases. He is the Associate Editor at the journals THORAX and ALLERGY.

Institution

Guy's & St Thomas' Hospitals, King's College London, London, United Kingdom

Country

United Kingdom

Day 2: Friday, 30th August 2024

Time	Session

10:35 11:50	Symposium 2B Noor Izyani Binti Zakaria Chairperson Azlina bt Samsudin Chairperson Malaysia PRIsm Theerasuk Kawamatawong Speaker Thailand COPD management with virtual medicine Sivakamasundari Narayani K Ampikaipakan Speaker United Kingdom Understanding the evolution of remission in severe asthma David Jackson Speaker United Kingdom Q&A Hall 302, Level 3
16:00 16:50	Sponsored Symposium 3A Company: AstraZeneca Azza Omar Chairperson Malaysia David Jackson Speaker United Kingdom Navigating between upstream & downstream targets in severe asthma Hall 301, Level 3

Day 3: Saturday, 31st August 2024

Time	Session

15:00 15:50	Sponsored Symposium 6 Company: GlaxoSmithKline Pang Yong Kek Chairperson Malaysia David Jackson Speaker United Kingdom Leong Hoe Nam Speaker Singapore Pang Yong Kek Speaker Malaysia From treatment to protection: Advances in asthma management and future of RSV prevention Hall 301, Level 3